Filing Details
- Accession Number:
- 0001209191-17-052911
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-09-15 13:13:05
- Reporting Period:
- 2017-09-15
- Accepted Time:
- 2017-09-15 13:13:05
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1428522 | Radius Health Inc. | RDUS | Pharmaceutical Preparations (2834) | 800145732 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1711694 | Jesper Hoiland | C/O Radius Health, Inc. 950 Winter Street Waltham MA 02451 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-09-15 | 6,100 | $32.72 | 6,100 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $32.688 to $32.7387, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of Common Stock purchased at each separate price.